Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
transcription factor AP-1
, which is composed of Fos and Jun family proteins, plays an essential role in tumor cell invasion by altering gene expression. We report here that Krp1, the AP-1 up-regulated protein that has a role in pseudopodial elongation in v-Fos-transformed rat fibroblast cells, forms a novel interaction with the nondifferentially expressed actin binding protein
Lasp-1
. Krp1 and
Lasp-1
colocalize with actin at the tips of pseudopodia, and this localization is maintained by continued AP-1 mediated down-regulation of fibronectin that in turn suppresses integrin and Rho-ROCK signaling and allows pseudopodial protrusion and mesenchyme-like invasion. Mutation analysis of
Lasp-1
demonstrates that its SH3 domain is necessary for pseudopodial extension and invasion. The results support the concept of an AP-1-regulated multigenic invasion program in which proteins encoded by differentially expressed genes direct the function, localization, and activity of proteins that are not differentially expressed to enhance the invasiveness of cells.
...
PMID:AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins. 1644 58
The process of tumor invasion requires degradation of extracellular matrix by proteolytic enzymes. Cancer cells form protrusive invadopodia, which produce and release matrix metalloproteinases (MMPs) to degrade the basement membrane thereby enabling metastasis. We investigated the effect of
LASP1
, a newly identified protein in invadopodia, on expression, secretion and activation of MMPs in invasive breast tumor cell lines.By analyzing microarray data of in-house generated control and
LASP1
-depleted MDA-MB-231 breast cancer cells, we observed downregulation of MMP1, -3 and -9 upon
LASP1
depletion. This was confirmed by Western blot analysis. Conversely, rescue experiments restored in part MMP expression and secretion. The regulatory effect of
LASP1
on MMP expression was also observed in BT-20 breast cancer cells as well as in prostate and bladder cancer cell lines.In line with bioinformatic FunRich analysis of our data, which mapped a high regulation of transcription factors by
LASP1
, public microarray data analysis detected a correlation between high
LASP1
expression and enhanced c-Fos levels, a protein that is part of the
transcription factor AP-1
and known to regulate MMP expression. Compatibly, in luciferase reporter assays, AP-1 showed a decreased transcriptional activity after
LASP1
knockdown.Zymography assays and Western blot analysis revealed an additional promotion of MMP secretion into the extracellular matrix by
LASP1
, thus, most likely, altering the microenvironment during cancer progression.The newly identified role of
LASP1
in regulating matrix degradation by affecting MMP transcription and secretion elucidated the migratory potential of
LASP1
overexpressing aggressive tumor cells in earlier studies.
...
PMID:Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1). 2758 91
LIM and SH3 domain protein 1
(
LASP-1
) is known to participate in the progression of hepatocellular carcinoma (HCC). We previously showed that ectopic expression of hepatitis B virus (HBV) X protein (HBX) enhanced the expression of
LASP-1
, which promoted proliferation and migration of HCC cells. Here, we further demonstrated the molecular mechanism underlying upregulation of
LASP-1
, mediated by HBX, in HBV-infected HCC cells. Through a luciferase activity assay, we discovered that the
LASP-1
promoter region regulated by HBX contained an AP-1 binding element in human hepatoma cells. Interestingly,
c-Jun
, one subunit of AP-1, was mainly responsible for activation, mediated by HBX, of the
LASP-1
promoter. Furthermore, HBX was shown not only to interact with phosphorylated
c-Jun
in HCC cells but also to activate
c-Jun
by increasing the activation of PI3-K/JNK signaling. Chromatin immunoprecipitation (ChIP) assay demonstrated that HBX was capable of binding to the
LASP-1
promoter with
c-Jun
. Further, the expression levels of HBX were shown to be significantly positively correlated with that of
LASP-1
and phosphorylatedc-Jun in HBV-related HCC tissues by immunohistochemistry analysis. In addition, the N-terminus of HBX was found to be responsible for the activation of
c-Jun
, as well as the expression of
LASP-1
. Taken together, these results suggest that HBX contributes to
LASP-1
expression via the activation of
c-Jun
to increase the promoter activity of
LASP-1
in HBV-related HCC cells.
...
PMID:HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells. 2960 May 94